IRIS
MELAIU, OMBRETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 619
EU - Europa 307
AS - Asia 33
SA - Sud America 2
Totale 961
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 618
IE - Irlanda 119
IT - Italia 103
GB - Regno Unito 24
DE - Germania 21
RU - Federazione Russa 16
SG - Singapore 13
FI - Finlandia 11
KR - Corea 5
AL - Albania 4
CZ - Repubblica Ceca 4
HK - Hong Kong 4
CN - Cina 3
BR - Brasile 2
JP - Giappone 2
MY - Malesia 2
SE - Svezia 2
TR - Turchia 2
BD - Bangladesh 1
CA - Canada 1
FR - Francia 1
KW - Kuwait 1
NL - Olanda 1
UA - Ucraina 1
Totale 961
Salva come PNG Salva come JPEG
Città #
Chandler 155
Dublin 119
New York 68
Rome 54
Wilmington 53
Fairfield 36
Ann Arbor 26
Medford 18
Moscow 16
Houston 14
London 12
Ashburn 11
Seattle 11
Woodbridge 11
Lawrence 9
Brooklyn 8
Cambridge 8
Mülheim 8
Würzburg 8
Lappeenranta 7
Singapore 7
Engelhard 6
Los Angeles 6
San Diego 6
Hounslow 5
Seoul 5
Center 4
Colorado Springs 4
Helsinki 4
Monte Vista 4
Nuremberg 4
Tirana 4
Torrita di Siena 4
Brno 3
Creede 3
Hong Kong 3
Kilburn 3
Naples 3
Nepi 3
Turin 3
Beijing 2
Gaeta 2
Genoa 2
Islington 2
Magenta 2
Norwalk 2
Palermo 2
Pontedera 2
Reggio Emilia 2
Selcuklu 2
Sondrio 2
Subang Jaya 2
Belgrade 1
Boardman 1
Cassano Magnago 1
Centrale 1
Chicago 1
Council Bluffs 1
Deiva Marina 1
Gopalganj 1
Guangzhou 1
Kuwait City 1
Miami 1
Milan 1
Munich 1
New Bedfont 1
Occhiobello 1
Osaka 1
Paris 1
Parma 1
Prescot 1
Redmond 1
Santa Maria a Vico 1
St. George 1
São Paulo 1
Toronto 1
Vicopisano 1
Totale 785
Salva come PNG Salva come JPEG
Nome #
ERAP1 promotes Hedgehog-dependent tumorigenesis by controlling USP47-mediated degradation of beta TrCP 103
Nutlin-3a Enhances Natural Killer Cell-Mediated Killing of Neuroblastoma by Restoring p53-Dependent Expression of Ligands for NKG2D and DNAM-1 Receptors 70
Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma 52
Identification of a Genetic Variation in ERAP1 Aminopeptidase that Prevents Human Cytomegalovirus miR-UL112-5p-Mediated Immunoevasion 43
ERAP1 controls the interaction of the inhibitory receptor KIR3DL1 with HLA-B51:01 by affecting natural killer cell function 35
ERAP1 controls the interaction of the inhibitory receptor KIR3DL1 with HLA-B51:01 by affecting natural killer cell function 35
Targeting the antigen processing and presentation pathway to overcome resistance to immune checkpoint therapy. 32
MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma 27
Polymorphisms within the RET proto-oncogene and risk of sporadic medullary thyroid carcinoma 25
Tumor-infiltrating T cells and PD-L1 expression in childhood malignant extracranial germ-cell tumors 25
Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors 25
Autophagy inhibition enhances T and NK immunogenicity in neuroblastoma 24
The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical Studies 24
Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism 22
Genetically driven CD39 expression shapes human tumor-infiltrating CD8+ T-cell functions 21
Counter-regulation of regulatory T cells by autoreactive CD8 + T cells in rheumatoid arthritis 20
DNA Damage Response Gene Signature as Potential Treatment Markers for Oral Squamous Cell Carcinoma 19
A methodological reappraisal of total and high molecular weight adiponectin determination in human peripheral circulation: comparison of four immunometric assays 19
PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma 18
Quantification of the immune content in neuroblastoma: Deep learning and topological data analysis in digital pathology 17
News on immune checkpoint inhibitors as immunotherapy strategies in adult and pediatric solid tumors 17
ERAP1 and ERAP2 enzymes: A protective shield for ras against COVID-19? 17
Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma 17
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines 17
Functional polymorphism within NUP210 encoding for nucleoporin GP210 is associated with the risk of endometriosis 17
The Multiple Roles of CD147 in the Development and Progression of Oral Squamous Cell Carcinoma: An Overview 16
Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma 16
Neoadjuvant Treatment as a Risk Factor for Variation of Upper Limb Lymph Node Drainage During Axillary Reverse Mapping in Breast Cancer: A Prospective Observational Study 16
Common gene variants within 3′-untranslated regions as modulators of multiple myeloma risk and survival 14
Characterization of novel 3′untranslated regions and related polymorphisms of the gene NPPC, encoding for the C-type natriuretic peptide 14
A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people 14
A comprehensive meta-analysis of case-control association studies to evaluate polymorphisms associated with the risk of differentiated thyroid carcinoma 14
The genetic susceptibility in the development of malignant pleural mesothelioma 13
Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma 13
A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma 13
Dendritic cells: Behind the scenes of t-cell infiltration into the tumor microenvironment 13
Editorial: Cell network in antitumor immunity of pediatric and adult solid tumors 13
Risk of differentiated thyroid carcinoma and polymorphisms within the susceptibility cancer region 8q24 13
A Novel Panel of Serum Biomarkers for MPM Diagnosis 12
Expression status of candidate genes in mesothelioma tissues and cell lines 12
Identification of overexpressed genes in malignant pleural mesothelioma 12
The Combination of Bioavailable Concentrations of Curcumin and Resveratrol Shapes Immune Responses While Retaining the Ability to Reduce Cancer Cell Survival 12
Eif4g1 and ran as possible drivers for malignant pleural mesothelioma 12
Correction: MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma (PLoS ONE (2017) 12:6 (e0180317) DOI: 10.1371/journal.pone.0085935) 11
Mesothelin promoter variants are associated with increased soluble mesothelin-related peptide levels in asbestos-exposed individuals 11
MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma 11
Role of genetic variations on MHC class I antigen-processing genes in human cancer and viral-mediated diseases 10
The regulatory roles of phosphatases in cancer 10
Clinical Feature Ranking Based on Ensemble Machine Learning Reveals Top Survival Factors for Glioblastoma Multiforme 8
Polymorphisms within base and nucleotide excision repair pathways and risk of differentiated thyroid carcinoma 7
DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy 7
Two bullets in the gun: combining immunotherapy with chemotherapy to defeat neuroblastoma by targeting adrenergic-mesenchymal plasticity 7
Impact of natural occurring erap1 single nucleotide polymorphisms within mirna-binding sites on hcmv infection 4
Totale 1.069
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.545
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.545
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202022 0 0 0 0 0 0 0 0 8 4 6 4
2020/2021135 5 6 5 5 6 4 69 5 11 5 10 4
2021/202298 27 6 1 0 0 9 5 3 6 9 7 25
2022/2023535 10 8 48 49 56 122 67 31 60 15 58 11
2023/2024260 29 16 20 6 35 68 12 7 12 20 4 31
2024/202519 19 0 0 0 0 0 0 0 0 0 0 0
Totale 1.069